Bone Biologics (BBLG): Company Cash Volume

Official company branding of Bone Biologics Corporation (BBLG)

The lack of sales and clinic expenses drive the dynamics of Bone Biologics (BBLG), as illustrated by the cash balance on the balance sheet, where the figure stood at 0.00. The innovative NELL-1 tissue regeneration platform creates growth potential within the orthopedics sector. Meanwhile, financial stability depends on the consistency of component supplies from Asia and US trade policy.

Company Cash Funds: Bone Biologics Inc (BBLG) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for Bone Biologics Corp. (BBLG)

- stock quotes and analyst forecast:
Initial company analysis:Bone Biologics Inc BBLG
Brand item of Bone Biologics Corp

Liquidity serves as the foundation for the survival of Bone Biologics (BBLG) during its clinical trial period. The dynamics of operating cash flow reflect the company's ability to fund the operation of contract manufacturing and the auditing of bone matrices. This metric aggregates available cash, allowing for an assessment of the burn rate relative to the pace of product development. Excess funds without reinvestment signal a decline in asset management efficiency. This balance determines the fair value of the business through the lens of financial autonomy.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume TNDM (Tandem Corp)|Company Cash Funds axogeninc.com|Company Cash on Hand SI-BONE, Inc. (SIBN)|Company Cash Volume OFIX|Bioventus Corp - Company Cash and Cash Equivalents|Company Cash Funds orthopediatrics.com KIDS|TMCI: Company Cash and Cash Equivalents|SRTA: Company Cash on Hand|Carlsmed Inc - Company Total Cash Amount|RxSight (RXST) - Company Cash Funds|Company Cash on Hand ClearPoint|Company Cash on Hand STXS|Company Cash Reserve Neuronetics, Inc. STIM|Company Cash Volume SGHT|Company Cash on Hand Orchestra BioMed OBIO|Company Cash Funds Anika Therapeutics Inc. ANIK|NSPR (InspireMD) - Company Total Cash Volume|ZJYL - Company Cash Funds|VANI (vivani.com) - Company Cash and Cash Equivalents|XTNT (Xtant Medical Inc) - Company Cash on Hand|Company Cash Reserve n1mtc.com (NMTC)|Company Cash Funds modular-medical.com|Company Cash and Cash Equivalents MYO (Myomo)|Company Cash Volume COCH|VVOS (Vivos Therapeutics, Inc) - Company Cash Balance|Company Cash Funds envveno.com NVNO|SINT - Company Cash on Hand|Tenon Medical Inc. - Company Cash Volume|LFWD: Company Cash Funds|Autonomix (AMIX) - Company Cash Funds|IVF - Company Liquid Assets|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)